Kolexia
Nicolas Virelizier Emmanuelle
Hématologie
Centre Léon-Bérard
Lyon, France
196 Activités
4 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Maladie de Hodgkin Récidive tumorale locale Lymphome folliculaire Lymphome B Lymphome B diffus à grandes cellules Lymphome malin non hodgkinien Leucémie myéloïde Leucémies

Industries

Sanofi
3 collaboration(s)
Dernière en 2023
Gilead
3 collaboration(s)
Dernière en 2023
Janssen
3 collaboration(s)
Dernière en 2022
Incyte
2 collaboration(s)
Dernière en 2022

Dernières activités

PROFILER: Program to Establish the Genetic and Immunologic Profile of Patient's Tumor for All Types of Advanced Cancer
Essai Clinique (Centre Léon-Bérard)   01 mars 2024
Phase 2 LYSA study of prednisone, vinblastine, doxorubicin, bendamustine for untreated older Hodgkin lymphoma patients.
Blood   18 novembre 2023
Impact of Brentuximab Vedotin in Patients with Breast Implant-Associated Anaplastic Large Cell Lymphoma with Capsule Infiltration Requiring Chemotherapy
65th ASH Annual Meeting Abstracts   02 novembre 2023
Long-Term Outcome of Multiple Myeloma Patients Receiving Autologous Stem Cell Transplantation (ASCT) - Impact of Therapeutic Strategy Following ASCT
65th ASH Annual Meeting Abstracts   02 novembre 2023
Spplaash Study: A Randomized Study to Evaluate the Incidence of Postdural Puncture Headache with the Use of Atraumatic Needles in Hematology
65th ASH Annual Meeting Abstracts   02 novembre 2023
Combining PET/CT and Ctdna Assessments at 6 Months from Induction Treatment Better Predicts Outcome in Previously Untreated Patients with Follicular Lymphoma: A Relevance Ancillary Lysa Study
65th ASH Annual Meeting Abstracts   02 novembre 2023
Post-transplantation Burkitt lymphoma: a retrospective study of 55 patients.
Haematologica   01 octobre 2023
Breast Implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) Registry
Essai Clinique (The Lymphoma Academic Research Organisation)   25 septembre 2023
PASCA: Study of Complications Related to Treatments in Adults Aged 18 to 65 Years Old Responding to a First Treatment in Oncology or Onco-hematology and Participating in the PASCA (PArcours de Santé au Cours du CAncer) Post-treatment Program.
Essai Clinique (Centre Léon-Bérard)   29 août 2023
OCAPI: An Interventional Prospective Study to Test the Feasibility of an Individualized Physical Activity Program in Patients Over 65 Years of Age With Hematologic Malignancies: the OCAPI Project.
Essai Clinique (Centre Léon-Bérard)   29 août 2023